Terug
Dagbereik
€ 21,58
€ 22,25
52-Weeksbereik
€ 11,86
€ 31,77
Volume
753.317
50D / 200D Gem.
€ 25,67
/
€ 21,49
Vorige Slotkoers
€ 22,29
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -167,8 | 0,3 |
| P/B | 14,3 | 2,9 |
| ROE % | -9,3 | 3,7 |
| Net Margin % | -4,3 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 33,33
+52.7%
Low: € 29,00
High: € 37,00
Forward K/W
65,9
Forward WPA
€ 0,34
WPA Groei (sch.)
+0,0%
Omzet Sch.
500 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,06
€ 2,99 – € 3,22
|
1,1 B | 2 |
| FY2029 |
€ 2,63
€ 2,57 – € 2,77
|
920 M | 4 |
| FY2028 |
€ 1,99
€ 1,44 – € 2,79
|
780 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -6,31M
Capital efficient — spends only 0,18% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)91,34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-9,30%
ROIC-4,68%
Net Margin-4,29%
Op. Margin-3,25%
Veiligheid
Debt / Equity
0,03
Current Ratio3,17
Interest Coverage-1,01
Waardering
P/E Ratio
-167,75
P/B Ratio14,29
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 91,34% | Revenue Growth (3Y) | 151,18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 376,07M | Net Income (TTM) | -16,14M |
| ROE | -9,30% | ROA | -3,73% |
| Gross Margin | 90,24% | Operating Margin | -3,25% |
| Net Margin | -4,29% | Free Cash Flow (TTM) | -6,31M |
| ROIC | -4,68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 3,17 |
| Interest Coverage | -1,01 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -167,75 | P/B Ratio | 14,29 |
| P/S Ratio | 7,20 | PEG Ratio | 2,58 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,71B | Enterprise Value | 2,67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376,07M | 196,54M | 59,61M | 3,69M | 0,0 |
| Net Income | -16,14M | -140,04M | -262,14M | -311,46M | -206,36M |
| EPS (Diluted) | -0,13 | -1,16 | -3,78 | -5,66 | -4,17 |
| Gross Profit | 339,38M | 177,41M | 54,62M | 2,93M | -763.000,0 |
| Operating Income | -12,23M | -128,40M | -241,10M | -301,63M | -206,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 432,97M | 348,89M | 341,37M | 449,27M | 408,15M |
| Total Liabilities | 243,49M | 191,35M | 252,70M | 239,69M | 110,48M |
| Shareholders' Equity | 189,48M | 157,54M | 88,67M | 209,58M | 297,68M |
| Total Debt | 6,27M | 110,59M | 205,92M | 202,54M | 77,56M |
| Cash & Equivalents | 42,91M | 71,34M | 88,40M | 53,64M | 97,99M |
| Current Assets | 411,23M | 335,82M | 330,43M | 437,41M | 402,77M |
| Current Liabilities | 129,84M | 81,01M | 46,67M | 37,81M | 33,33M |